Literature DB >> 15806273

Hypercoagulable states: a review.

Colleen M Johnson1, Leila Mureebe, Donald Silver.   

Abstract

Vascular surgeons are often asked to evaluate patients with recurrent thromboses or thromboses in unusual locations either arterial or venous. There may be obvious inciting factors, but in many of these patients the possibility of a previously undiagnosed hypercoagulable state must be considered. Hypercoagulable states can be acquired (smoking, medication, change in physiologic status as occurs with pregnancy) or congenital. Congenital hypercoagulable disorders are more prevalent in families or patients with a history of thromboembolic events early in life or multiple miscarriages and include conditions such as protein C or S deficiencies, factor V Leiden mutation, and prothrombin gene variant. This article reviews the hypercoagulable states that are encountered in clinical practice as well as guidelines for testing and goals of therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15806273     DOI: 10.1177/153857440503900201

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  4 in total

Review 1.  The clinical significance of coagulation and the inflammatory response in autoimmunity.

Authors:  Benjamín Rubio-Jurado; Paulina Iñiguez-Franco; Pedro A Reyes; Gustavo Robles; Mario Salazar-Páramo; Guadalupe Zavala-Cerna; Carlos Riebeling; Arnulfo Nava
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 2.  Microthrombotic/microangiopathic manifestations of the antiphospholipid syndrome.

Authors:  Sonja Praprotnik; Dusan Ferluga; Alenka Vizjak; Anastazija Hvala; Tadej Avcin; Blaz Rozman
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

3.  Plantar vein thrombosis: a rare cause of plantar foot pain.

Authors:  Daniel S Siegal; Jim S Wu; Darren D Brennan; Tracy Challies; Mary G Hochman
Journal:  Skeletal Radiol       Date:  2007-12-05       Impact factor: 2.199

4.  Factors associated with ischemic stroke on therapeutic anticoagulation in patients with nonvalvular atrial fibrillation.

Authors:  Young Dae Kim; Kyung Yul Lee; Hyo Suk Nam; Sang Won Han; Jong Yun Lee; Han-Jin Cho; Gyu Sik Kim; Seo Hyun Kim; Myoung-Jin Cha; Seong Hwan Ahn; Seung-Hun Oh; Kee Ook Lee; Yo Han Jung; Hye-Yeon Choi; Sang-Don Han; Hye Sun Lee; Chung Mo Nam; Eun Hye Kim; Ki Jeong Lee; Dongbeom Song; Hui-Nam Park; Ji Hoe Heo
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.